AC Immune SA, a Lausanne-based clinical-stage biopharmaceutical company pioneering precision therapeutics for neurodegenerative diseases, announces that Dr Andrea Pfeifer has…

The Robert Wenner Prize, which recognises scientists in the field of cancer research, is being awarded this year for the…

After first announcing a partnership in 2022, the Lausanne-based neurotech company aims to speed up the launch of its digital…

Bewe Lab and Perivision are among the four companies selected by Canton de Vaud and the Swiss Data Science Center…

Geneva-based startup Immitra Bio has been selected as one of the latest winners of the InnoBooster programme, supported by the…

HAS Healthcare Advanced Synthesis (Ticino) and Biodelphis Therapeutics (Vaud) announced the signing of a strategic agreement to support the development…

Moonlight AI AG, a Swiss startup building image analysis software for clinical-grade diagnostics, has closed a $3.3 million USD Seed…

Switzerland’s biotech sector continues to demonstrate remarkable resilience and growth, even in a complex global environment. According to the latest…

Up to 400 patients per year could benefit from the “Da Vinci Single Port” system, developed by Intuitive Surgical, which…

Two research groups from Hôpitaux Universitaires de Genève (HUG) and Université de Genève (UNIGE) have been awarded the 2026 Leenaards…

In Switzerland, precision and innovation are more than values—they are an industrial signature. Few companies embody that better than Medtronic,…

MindMaze Therapeutics’ 2025 Annual Report tells a story of transition—one where financial discipline begins to align with long-term commercial ambition….